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GENECALLING® EXPRESSION ANALYSIS IN ARTICULAR 
CARTILAGE 
GL Pahel, EP Dixon, AA Cole, G Cs-Szabo, KE Quinn 
DepL of Molecular Phannacology, GlaxoSmithKline, RTP, NC; 
Dept of Biochemistry, Rush Medical College, Rush-Presbyterian- 
St. Lukes Medical Center, Chicago,/L; CuraGen Corp., New 
Haven, CN, USA 
Aim: The aim of this study was to use the open ended CuraGen 
expression analysis system to identify those genes whose 
expression most differed between cartilage graded as non-dis- 
eased and osteoarthritic cartilage. 
Methods: Non-diseased (Collins grade 0) knee cartilage came 
from the tibial plateau of donor's identified through the Regional 
Organ Bank of Illinois. Osteoarthritic cartilage came from 
• osteoarthritic patients undergoing total knee replacement. RNA 
was isolated using modifications of published methods. The 
expression analysis was carried out at CuraGen Corporation 
using their proprietary differential display GeneCalling technolo- 
gy. Selected observations were verified by quantitative real time 
PCR (SyberGreen) and extended by in situ analysis. 
Results: We have identified over 50 transcripts exhibiting a 
greater than four-fold ifference between normal and OA carti- 
lage. The direction, although not necessarily the magnitude, of 
many of these changes has been verified by PCR. Among those 
transcripts up regulated in OA were collagen types ], II, III, V, and 
XIV, cartilage glycoprotein-39 (YKL-40), osteopontin, throm- 
bospondin-like, several novel secreted proteins, and novel tyro- 
sine and serine/threonine receptor signalling kinases, Expected 
genes found to be up regulated, but less than four-fold included 
biglycan, aggrecan, tenascin, and osteonectin. Five transcription 
factors and an orphan G-protem coupled receptor were found to 
be down regulated. Expression of pro- and antiapoptosis genes 
was also regulated confirming a role for apoptosis in OA. 
Conclusion: GeneCalling® expression analysis is a robust 
method to identify gene expression changes in cartilage. It has 
been useful in confirming expected changes and in the identifi- 
cation of potential novel targets for therapeutic intervention and 
markers of disease. 
PP38 
ASSOCIATION OF HETEROZYGOUS HEMOCHROMATOSIS 
C282Y GENE MUTATION WITH HAND OSTEOARTHRITIS 
J. M. Ross R. Kowlchuck, R Phatatk 
Pennsylvania State Medical School, Hershey, PA, USA 
Aim: Since hereditary hemochromatosis (homozygous tate) usu- 
ally causes a severe form of osteoarthdtis, the aim of the study 
was to determine if radiographic osteoarthritis of the hand is 
associated with an increased prevalence of heterozygous C282Y 
and/or H63D hemochromatosis (HFE) gene mutation. 
Methods: 176 subjects from an academic rheumatology practice 
with hand osteoarthritis (OA) entered a cross-sectional study 
assessing transferrin saturation, ferritin levels, and prevalence of 
HFE genotypes. The diagnosis of radiographic hand QA was 
based on one PA radiograph of both hands with a Kellgren- 
Lawrence grade of =2 in at least one joint in either hand. 
Prevalence of HFE mutations in the local general population 
including subjects with and without OA was determined and 
compared with OA subjects. 
Results: There was a significant increased prevalence of 
C282Y/wild type (wt) HFE mutation in 12.5 % of the OA popula- 
tion compared with a general population prevalence of 7.8% with 
a p-value of 0.029. The significance of increased prevalence of 
OA and heterozygous C282Y mutation was greater in subjects 
360 years of age with p-value of 0.008. There were 23 men with 
OA enrolled with 5 having the C282Y allele. The mean transferrin 
saturation for the wild type OA population was 25.93 and the het- 
erozygous C282Y/wt OA population had a mean of 35.75 with a 
p-value of <0.0001. 
Conclusion: Our data suggests that one subset of OA may be 
related to heterozygous C282Y LIFE mutation and could account 
for up to 12.5% of cases of hand OA in the general population. If 
substantiated the significance of HFE mutations could be much 
greater than that of any other currently known genetic OA asso- 
ciations since HFE testing might be directly tied to simple pre- 
ventative measures with phlebotomy. 
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JAK/STAT BUT NOT ERKI/ERK2 PATHWAY MEDIATES IL- 
6/slL- 6-R DOWN-REGULATION OF COLLAGEN TYPE !1 AND 
AGGRECAN EXPRESSION IN ARTICULAR CHONDROCYTES 
F Richard-Legendre, J-P Pujol, P Bogdanowicz 
Laboratory of Connective Tissue Biochemistry, Faculty of 
Medicine, 14032 CAEN Cedex, France 
Aim: The aim of this study was to analyze the signaling pathways 
of IL-6/slL-6R in articular chondrocytes and their involvement i  
the control of matrix gene expression. 
Methods: Bovine articular chondrocytes, seeded at 5.5x105 
cells/cm 2, were treated by IL-6 (100 to 500 ng/ml) with or without 
IL-6sR (200 to 500 ng/ml) for increasing periods (0 to 30 min) in 
the case of signaling analysis and 24 h for gene expression stud- 
ies. Western-blotting and gel r tardation assays were performed 
with or without MAP kinase inhibitor (PD 98059, 25 ~.M) and STAT 
inhibitor (parthenolide, 25 ~.M). Collagen type 11 and aggrecan 
mRNA levels were determined by Northern blots. 
Results: In the absence of slL-6R, 11_-6 (500 ~g/ml) had a slight 
effect on JAK-1 and JAK-2 phosphorylation. Addition of slL-6R at 
500 ng/ml dramatically increased these effects, with a peak at 15 
min. STATs 1 and 3 were also found to be phosphorylated and 
translocated to the nucleus. Increased binding of protein factors 
to specific STAT responsive elements was observed. ERK 1 and 
ERK 2 were activated by IL-6/slL-6R treatment, with a maximum 
at 30 min. Exposure of cells to IL-6/slL-6R induced an inhibition 
of collagen type II and aggrecan expression. This down-regula- 
tion was abolished in the presence of STAT- but not of MAPK- 
inhibitor, indicating that STAT signaling pathway is implicated in 
the control of these two cartilage specific matrix genes. 
Conclusions: To exert significant effect on chondrocytes, IL-6 
requires the presence of its soluble receptor. The cytokine plays 
a role in the cartilage breakdown through a STAT-induced inhibi- 
tion of collagen type 11 and aggrecan expression. 
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ANALYSIS OF THE ANK GENE REVEALS A HETEROZYGOUS 
MISSENSE MUTATION IN A FRENCH FAMILY WITH CALCI- 
UM PYROPHOSPHATE DEPOSITION DISEASE (CPPDD) 
M Johnson 1 , A Ho 1, R McGrath 2, P Netter 3, D Loeuille 3, P 
Gillet 3, P Jonveaux 3, A Gaucher 3, 
A Reg nato 4, K Gur ey,' D Kings ey', C J W ams 2- 
WHMI and Stanford University, CA, USA; 2Thomas Jefferson 
University, PA, USA, 3UMR 7561, CNRS-UHP, Nancy, France, 
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Aim : To characterize the ANK gene in a large CPPDD kindred 
from the Alsace region of France. 
Methods and Results: ANK codes for an integral membrane pro- 
tein that apparently functions in the transport of inorganic 
pyrophosphate (PPi). In light of numerous reports of anomalous 
regulation of PPi metabolism in patients with CPPDD, we ana- 
lyzed the ANK gene in a large French family. Direct sequencing of 
all exons of the gene revealed a heterozygous base substitution 
in exon 2 that changed a methionine to a threonine at amino acid 
position 48. No other amino acid changes were detected, and 
there was no evidence of any other sequence anomaly at 
intron/exon splice sites, nor in a region of the 5' UTR. The M~T 
sequence variant completely segregated with the disease pheno- 
type in the family. Furthermore, analysis of 200 alleles from con- 
trol subjects did not detect this missense mutation. 
Conclusions: Familial CPPDD is a genetic disorder that maps to 
chromosome 5p15.1 (locus name: CCAL2). Among the positional 
candidates in the disease interval is ANK, the human homolog of 
the mouse progressive ankylosis (ank) gene. In recessive ank/ank 
mice, loss of ank activity leads to a drop in extracellular PPi lev- 
els, resulting in unregulated apatite calcification in joints. 
Dominant mutations in ANK have recently been reported in 
Jackson-type cranial metaphyseal dysplasia (CMD) and it has 
been suggested that mutations in ANK in CMD patients result in 
decreased levels of extraceilular PPi, causing the increased bone 
density that is characteristic of CMD. We observed an M-T 
sequence variant in ANK in a French kindred with dominant 
CPPDD. It does not appear to significantly alter primary structure 
conformational parameters, nor does it affect the predicted sec- 
ondary structure of the protein. Nonetheless, position 48 and sur- 
rounding regions of the ANK protein are highly conserved in a 
variety of different vertebrates, including humans, frogs, and fish. 
The high degree of evolutionary conservation suggests that 
amino acid changes at this position are likely to have a deleteri- 
ous effect on ANK function. Studies to evaluate the impact of this 
missense mutation on the transport of PPi are underway. 
(Supported by AR44360, PHRC 1997, and the Howard Hughes 
Medical Institute). 
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GENE TRANSFER INTO JOINTS BY ELECTROPORATION 
IN VIVO 
S Ohashi, 0 Mazda, T Kishida, K Takahashi, Y Arai, T Ikeda, 
R Terauchi, J Imanishi, T Kubo 
Departments of Orthopaedic Surgery and Department of 
Microbiology, 
Kyoto Prefectural University of Medicine, Kyoto, Japan 
Aim: Joint diseases are not lethal, therefore, absolute safety and 
high efficacy are required in gene therapies for joints. The pur- 
pose of this study was to develop an efficient non-viral gene 
delivery system for joint tissues using the electroporation i vivo. 
Materials and Methods: The expression vector pGEG.GL3 was 
composed of the luciferase gene under the control of the CAG 
promoter. The Epstein-Barr virus (EBV) oriP and EBV nuclear anti- 
gen (EBNA) 1 gene, which were the structures for the latent infec- 
tion by EBV, located downstream of another CAG promoter. The 
conventional vector, pG.GL.3, carries the luciferase gene driven 
by the CAG promoter but not EBNA 1 gene nor oriR Fifty micro- 
gram of the plasmids were injected into the knee joints of Dark 
Agouti (DA) rats, and different voltages of electric pulses (25- 
500V) were applied transcutaneously. Three days after the trans- 
fection, the synovium was collected and the luciferase activity 
was measured. 
Results: Marked enhancement of luciferase expression was 
observed when an electric pulse was applied after intra-articular 
DNA injection. The highest luciferase activity was achieved in the 
joints pulsed at 200V. The expression level of the electrotrans- 
ferred DNA was much higher than that of naked DNA delivered 
without electric pulsation (up to 600-fold). Up to 8-fold higher 
luciferase activity was demonstrated with pGEG.GL3 than with 
pG.GL.3. 
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Conclusions: In the present study, quite high transfection effi- 
ciency into synovium was achieved by intra-articular injection of 
naked plasmid DNA followed by an electric pulsation. The EBV- 
based plasmid vector augmented the transfection efficiency. The 
results demonstrated that the electroporation i vivo using EBV- 
based plasmid vector could provide a useful and safe method for 
the direct intra-articular gene delivery for joint diseases. 
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COMPARISON OF TWO COLLAGEN MUTANT MOUSE LINES 
THAT SERVE AS MODELS OF EARLY-ONSET 
OSTEOARTHRITIS IN HUMAN CHONDRODYSPLASIA 
R.E. Seeamilier, V Ryder, R Jackson, R Rodriguez, H Vu, 
W Babcock, R Poole*, R Crowe, L Bridgewater 
Department of Zoology, Brigham Young University, Provo, UT, 
USA; *Shriners Hospital, Montreal, Quebec, Canada 
Aim: The aim of this study was to establish two collagen mutant 
mouse lines as separate animal models for the study of early- 
onset osteoarthritis (CA) in the human chondrodysplasias, e.g., 
Stickler syndrome. Experiments were designed to determine the 
extent of the degenerative changes in articular cartilage and to 
establish the age of onset of the disease. 
Methods: With wild-type (+/+) littermates erving as controls, 
knee-joints from heterozygous mice carrying the semidominant 
Col2al mutation Disproportionate micrometia (Dram) or the 
recessive Colllal mutation chondrodysplasia (cho) were exam- 
ined with histological (H&E), histochemical (safranin O), ultra- 
structural, and immunofluorescence (col2-3/4m antibody for 
detecting degraded type II collagen) techniques. 
Results: In both mutants, degenerative changes were observed 
in articular cartilage several months prior to being observed in the 
control group. Morphological changes included alterations in 
organization and number of chondrocytes, staining of the matrix, 
and extent of fibrillogenesis. These changes were typically 
observed in the superficial zone but extended into the transition- 
al zone. Likewise, degraded collagen was detected primarily in 
the superficial and transitional zones in both mutants. Overall, 
these changes were more pronounced in mice carrying the Dram 
gene compared with mice carrying the cho gene. 
Conclusions: These results support the hypothesis that mice 
carrying the Dmm and cho genes develop premature CA, and 
thus provide the opportunity of studying chondrodysplasia-asso- 
ciated degeneration of articular cartilage as early as 6 months in 
two different murine models. Our observations uggest that the 
dominant-negative effect of the Dram gene predisposes articular 
cartilage to more severe and earlier onset CA than does the 
apparent hap]oinsufficiency caused by the recessive cho muta- 
tion. Study of these two mutations in mice provides the opportu- 
nity of elucidating the mechanism and of providing early diagno- 
sis and therapy for chondrodysplasia-associated CA
